Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Lugaresi

Showing results (41-50 of 201) with videos related to

Pageof 21
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 30, 2021
The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter studyGaetano Bernardi, Tiziana Biagioli, Paola Malpassi, et al.
Molecular Biosystems|February 19, 2015
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosisDamiana Pieragostino, Michele D'Alessandro, Maria di Ioia, et al.
BMC Neurology|April 3, 2014
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trialAlice Laroni, Davide Brogi, Vincenzo Brescia Morra, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|April 28, 2015
Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosureKatia Mattarozzi, Federica Casini, Elisa Baldin, et al.
Experimental Gerontology|March 31, 2004
IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitorsAlessandra Lugaresi, Angelo Di Iorio, Carla Iarlori, et al.
Journal of the Neurological Sciences|June 2, 2017
Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?Cristina Scarpazza, Luca Prosperini, Chiara R Mancinelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 21, 2016
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in ItalyAlice Laroni, Davide Brogi, Vincenzo Brescia Morra, et al.
Scientific Data|June 4, 2024
Multiparametric MRI dataset for susceptibility-based radiomic feature extraction and analysisCristiana Fiscone, Giovanni Sighinolfi, David Neil Manners, et al.
Journal of Proteomics|November 17, 2009
A computational platform for MALDI-TOF mass spectrometry data: application to serum and plasma samplesDante Mantini, Francesca Petrucci, Damiana Pieragostino, et al.
Scientific Reports|September 27, 2023
Assessing robustness of quantitative susceptibility-based MRI radiomic features in patients with multiple sclerosisCristiana Fiscone, Leonardo Rundo, Alessandra Lugaresi, et al.
Pageof 21

Showing results (41-50 of 201) with videos related to

Sort By:
Pageof 21
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 30, 2021
The contribute of cerebrospinal fluid free light-chain assay in the diagnosis of multiple sclerosis and other neurological diseases in an Italian multicenter studyGaetano Bernardi, Tiziana Biagioli, Paola Malpassi, et al.
Molecular Biosystems|February 19, 2015
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosisDamiana Pieragostino, Michele D'Alessandro, Maria di Ioia, et al.
BMC Neurology|April 3, 2014
Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trialAlice Laroni, Davide Brogi, Vincenzo Brescia Morra, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|April 28, 2015
Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosureKatia Mattarozzi, Federica Casini, Elisa Baldin, et al.
Experimental Gerontology|March 31, 2004
IL-4 in vitro production is upregulated in Alzheimer's disease patients treated with acetylcholinesterase inhibitorsAlessandra Lugaresi, Angelo Di Iorio, Carla Iarlori, et al.
Journal of the Neurological Sciences|June 2, 2017
Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?Cristina Scarpazza, Luca Prosperini, Chiara R Mancinelli, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 21, 2016
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in ItalyAlice Laroni, Davide Brogi, Vincenzo Brescia Morra, et al.
Scientific Data|June 4, 2024
Multiparametric MRI dataset for susceptibility-based radiomic feature extraction and analysisCristiana Fiscone, Giovanni Sighinolfi, David Neil Manners, et al.
Journal of Proteomics|November 17, 2009
A computational platform for MALDI-TOF mass spectrometry data: application to serum and plasma samplesDante Mantini, Francesca Petrucci, Damiana Pieragostino, et al.
Scientific Reports|September 27, 2023
Assessing robustness of quantitative susceptibility-based MRI radiomic features in patients with multiple sclerosisCristiana Fiscone, Leonardo Rundo, Alessandra Lugaresi, et al.
Pageof 21